Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytodyn Inc
(OP:
CYDY
)
0.2000
+0.0211 (+11.79%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytodyn Inc
< Previous
1
2
3
Next >
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Group of CytoDyn Stockolders Responds to Misleading Company News Release
September 07, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Highlights Court Ordering Rosenbaum/Patterson Group to Comply With the Federal Securities Laws
September 02, 2021
From
CytoDyn Inc.
Via
Business Wire
Group of CytoDyn Stockholders Warns Stockholders of Board’s Continued Value Destruction and Failures
September 02, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
Group of CytoDyn Stockholders Files Lawsuit to Force Company to Allow Stockholders to Vote for Alternative Director Nominees
August 26, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Urges Shareholders to Ignore Proxy Cards from Rosenbaum/Patterson Group
August 25, 2021
From
CytoDyn
Via
Business Wire
Group of CytoDyn Stockholders Responds to Highly Misleading Company Release
August 19, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Provides Update on Rosenbaum/Patterson Group Litigation
August 19, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Files Lawsuit Against Rosenbaum/Patterson Activist Group for Misleading Shareholders and Waging an Unlawful Proxy Contest
August 05, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients
August 03, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Announces That Director Nominations by Rosenbaum/Patterson Activist Group Are Invalid
August 02, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Inc. (OTC: CYDY) Long Term Investor Notice: Investigation of Potential Wrongdoing
July 28, 2021
San Diego, CA -- (SBWIRE) -- 07/28/2021 -- An investigation on behalf of current long term investors in CytoDyn Inc. (OTC: CYDY) shares over possible breaches of fiduciary duty by certain officers and...
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
July 28, 2021
Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility...
Via
Benzinga
Group of Cytodyn Stockholders Nominates Five Highly Qualified Director Candidates to Replace Board Responsible for Mismanagement and Value Destruction
July 01, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
What's Behind This Wild-Card Coronavirus Stock?
June 08, 2021
Failure is not an option for this small-cap biotech developing a COVID-19 treatment.
Via
The Motley Fool
Exposures
COVID-19
CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
May 18, 2021
After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140...
Via
Benzinga
Exposures
COVID-19
Product Safety
CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
May 18, 2021
The FDA has accused CytoDyn Inc (OTC: CYDY) of trying to pick and choose data from two failed studies of leronlimab in COVID-19 patients to claim the drug is...
Via
Benzinga
Exposures
COVID-19
Product Safety
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 14, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against CytoDyn, Inc. and Encourages Investors to Contact the Firm
May 13, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)
May 13, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
These OTC Securities Had the Most Trading Activity in April
May 12, 2021
April was another fascinating month in OTC Markets trading, as cryptocurrency, internatio...
Via
Benzinga
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 11, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
May 10, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Review Of Present Therapies For Covid-19
May 09, 2021
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
Via
Talk Markets
Exposures
COVID-19
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CYDY
May 02, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
CytoDyn Inc. (OTC:CYDY) Investor Notice: Lawsuit Alleges Misleading Statements by CytoDyn Inc
April 27, 2021
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- An investor, who purchased shares of CytoDyn Inc. (OTC:CYDY), filed a lawsuit against CytoDyn Inc over alleged violations of Federal Securities Laws.
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.